Avalo Therapeutics AVTX Ratios (2014-2026)

NASDAQ AVTX
$19.23 +0.23 (+1.21%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

Avalo Therapeutics Quarterly Ratios

Periods 46 quarters
Latest Jun 2026

Avalo Therapeutics ratios data for the quarter ended Jun 2026. These financial ratios cover 46 quarters of results from Sep 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Sep2014 Dec2014 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
32.74%-93.61%38.62%-51.69%96.47%30.80%-16.00%-10.11%-4.66%138.70%-186.75%
EBT Margin
-1,293.56%-8,742.92%-1,879.11%-1,256.73%21.39%-1,094.20%-2,094.11%-1,273.09%-2,211.86%-1,432.05%9,246.18%-18,346.35%-23,033.90%
EBIT Margin
-1,219.48%-8,202.28%-1,777.75%-1,145.01%27.39%-988.28%-1,850.95%-1,111.98%-1,588.98%-1,341.16%-5,165.06%-6,932.81%-33,461.02%
EBITDA Margin
-1,219.48%-8,202.28%-1,777.75%-1,145.01%27.39%-988.28%-1,850.95%-1,111.98%-1,588.98%-1,341.16%-5,165.06%-6,932.81%-33,461.02%
Operating Margin
-1,219.48%-8,202.28%-1,777.75%-1,145.01%27.39%-988.28%-1,850.95%-1,111.98%-1,588.98%-1,341.16%-5,165.06%-6,932.81%-33,461.02%
Net Margin
-1,288.52%-8,774.43%-1,879.88%-1,257.21%21.35%-1,095.09%-2,095.79%-1,274.18%-2,215.25%-1,430.47%9,251.81%-18,405.73%-23,254.24%
FCF Margin
-1,353.26%-7,351.14%-1,369.74%-1,212.58%38.04%-439.73%-2,149.47%-1,714.77%-2,896.61%-484.41%-4,629.32%-7,835.42%-24,216.95%
Efficiency
Inventory AverageInventory Avg.
0.02M0.03M0.03M0.02M0.02M0.02M0.02M0.02M
Assets AverageAssets Avg.
79.72M87.78M71.06M47.06M34.39M34.96M34.80M30.23M26.75M25.13M72.36M116.02M103.38M124.59M144.63M132.55M125.84M120.78M108.17M295.33M
Invested CapitalInvested Cap.
72.79M55.91M39.52M12.76M17.04M8.50M13.50M7.15M14.70M7.30M133.39M122.97M104.94M91.55M83.05M
Asset Utilization RatioAsset Util.
0.080.060.090.080.510.520.500.560.080.080.020.010.010.000.000.00
Leverage & Solvency
Interest Coverage RatioInterest Cover
Debt Ratio
0.340.410.540.580.520.580.550.580.000.000.00
Times Interest Earned
Valuation
Price to EarningsP/E
-14.09-9.99-3.71-4.359.80-4.85-2.32-0.61-1.08-0.31-0.150.132.29-0.93-6.60-2.60-5.81-17.74-10.20-22.16
Price to SalesP/S
181.51876.2769.7454.672.0953.0948.677.7623.944.43211.60171.280.00M
Price to BookP/B
6.088.3112.90-9.49-15.42-4.36-3.69-0.720.380.35-0.17-0.952.500.250.710.521.942.932.931.80
Enterprise Value
173.54M137.32M43.34M45.23M14.34M34.40M6.43M-1.32M-4.53M-4.89M-91.49M-80.53M-29.17M-101.66M-38.32M-59.18M66.33M145.10M118.14M405.49M
EV to EBIT
-10.54-7.64-2.08-3.823.50-3.88-0.730.181.210.642.798.412.277.642.613.06-3.45-7.35-5.65-12.87
EV to EBITDA
-10.54-7.64-2.08-3.823.50-3.88-0.730.181.210.642.798.412.277.642.613.06-3.45-7.35-5.65-12.87
Market Capitalization
245.04M191.90M81.81M56.48M31.28M47.57M23.12M4.99M5.65M2.53M18.69M12.90M52.69M32.89M86.73M54.08M177.95M243.43M200.13M805.77M
Price to FCFP/FCF
-13.41-11.92-5.09-4.515.50-12.07-2.26-0.45-0.83-0.91-3.01-0.79-4.57-2.19-9.17-4.75-10.87-17.04-11.31-40.29
EV to FCF
-9.50-8.53-2.70-3.612.52-8.73-0.630.120.661.7714.754.952.536.764.055.20-4.05-10.16-6.67-20.27
EV to CFO
-10.65-8.03-2.70-3.632.50-8.73-0.640.120.661.7714.754.952.536.764.055.20-4.05-10.16-6.67-20.27
Return Ratios
Return on Sales [ROS]ROS
-1,219.48%-8,202.28%-1,777.75%-1,145.01%27.39%-988.28%-1,850.95%-1,111.98%-1,588.98%-1,341.16%-3,539.66%-6,660.47%-5,165.06%-6,932.81%-15,078.00%-33,461.02%
Return on Capital Employed [ROCE]ROCE
-132.68%-120.97%-136.20%-211.92%-286.69%-291.53%-219.63%-266.06%-137.59%-133.33%35.81%-273.95%-147.19%-58.24%-36.27%-48.79%-56.41%-67.62%-81.97%-33.32%
Return on Invested Capital [ROIC]ROIC
-143.74%-127.36%-151.38%-256.78%-312.55%-293.40%-230.93%-200.78%-261.65%-248.76%-39.27%-52.93%-67.78%-83.71%
Return on Assets [ROA]ROA
-101.38%-96.14%-106.63%-152.25%-148.50%-119.17%-84.95%-81.92%-124.06%-125.52%-197.45%-31.22%-7.70%-28.19%50.48%-34.87%-79.37%-64.80%-78.34%-33.97%